Update In Sexually Transmitted Infections An Issue Of Infectious Disease Clinics

This issue of the Infectious Disease Clinics is devoted to the treatment and prevention of the most common STDs – including syphilis, gonorrhea, herpes, and HPV. The articles will discuss the current research in the field such as antimicrobial resistance in treating gonorrhea and the development/trials of a genital herpes vaccine.

In this issue of Infectious Disease Clinics of North America, guest editor Dr. Jeanne Marrazzo brings her considerable expertise to the topic of Sexually Transmitted Infections. The CDC approximates that 20% of Americans have experienced a sexually transmitted infection (STI), and the World Health Organization has estimated that over 340 million people live with STIs worldwide every year. In this issue, top experts provide important updates in this area, with goals to provide the relevant clinical information to aid physicians in prevention, diagnosis, and management. Contains 14 practice-oriented topics including syphilis: a modern resurgence; update in management and prevention of chlamydial infections; non-herpes and non-syphilis causes of genital ulcer disease (including monkeypox, LGV, chancroid); diagnostic advances in sexually transmitted infections; immunizations for sexually transmitted infections; and more. Provides in-depth clinical reviews on sexually transmitted infections, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Infectious Disease Clinics of North America, guest editor Dr. Jeanne Marrazzo brings her considerable expertise to the topic of Sexually Transmitted Infections. The CDC approximates that 20% of Americans have experienced a sexually transmitted infection (STI), and the World Health Organization has estimated that over 340 million people live with STIs worldwide every year. In this issue, top experts provide important updates in this area, with goals to provide the relevant clinical information to aid physicians in prevention, diagnosis, and management. Contains 14 practice-oriented topics including syphilis: a modern resurgence; update in management and prevention of chlamydial infections; non-herpes and non-syphilis causes of genital ulcer disease (including monkeypox, LGV, chancroid); diagnostic advances in sexually transmitted infections; immunizations for sexually transmitted infections; and more. Provides in-depth clinical reviews on sexually transmitted infections, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

The WHO global health sector strategy on sexually transmitted infections, 2016–2021, endorsed by the World Health Assembly in 2016, aims to eliminate STIs as a public health threat by 2030. In 2019, WHO published estimates of new cases of chlamydia, gonorrhoea, syphilis and trichomoniasis. Recent changes in the epidemiology of STIs and progress in prevention, diagnosis and treatment of STIs and HIV have necessitated changes in approaches to STI prevention and management. To address these STIs, the most widely used approach in clinical settings is the syndromic management of STIs. In most resource-limited settings, the syndromic management flow charts are still the standard of care where laboratory diagnosis is not available or is hard to access. The objectives of these guidelines are to provide updated, evidence-informed clinical and practical recommendations on the case management of people with symptoms of STIs; and to support countries in updating their national guidelines for the case management of people with symptoms of STIs. These guidelines include the management of symptomatic infections related to urethral discharge syndrome, including persistent urethral discharge syndrome; vaginal discharge syndrome, including persistent vaginal discharge; anorectal infection; genital ulcer disease syndrome; and lower abdominal pain syndrome. These guidelines are intended for programme managers for STI prevention and control at the national level and the health-care providers at the frontline – primary, secondary and tertiary health care.

One in five people in the United States had a sexually transmitted infection (STI) on any given day in 2018, totaling nearly 68 million estimated infections. STIs are often asymptomatic (especially in women) and are therefore often undiagnosed and unreported. Untreated STIs can have severe health consequences, including chronic pelvic pain, infertility, miscarriage or newborn death, and increased risk of HIV infection, genital and oral cancers, neurological and rheumatological effects. In light of this, the Centers for Disease Control and Prevention, through the National Association of County and City Health Officials, commissioned the National Academies of Sciences, Engineering, and Medicine to convene a committee to examine the prevention and control of sexually transmitted infections in the United States and provide recommendations for action. In 1997, the Institute of Medicine released a report, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Although significant scientific advances have been made since that time, many of the problems and barriers described in that report persist today; STIs remain an underfunded and comparatively neglected field of public health practice and research. The committee reviewed the current state of STIs in the United States, and the resulting report, Sexually Transmitted Infections: Advancing a Sexual Health Paradigm, provides advice on future public health programs, policy, and research.

Sexually Transmitted Diseases: A Guide for Primary Care, second edition, covers the diagnosis and treatment of STDs and other information critical to patient care and reflects the last five years of significant changes in information about STDs. Updated to reflect the 2010 Center for Disease Control Guidelines on the Treatment of STDs, this book also contains new information about: -the epidemiology of herpes virus infections -expedited partner therapy -changes in recommendations for HPV vaccination for men -changes in resistance patterns for antimicrobial therapy for gonorrhea and chlamydia -treatment recommendations for bacterial vaginosis -treatment recommendations for genital warts In order to better meet clinician needs, the book has been streamlined to quickly convey critical, evidence-based information. Whether seeking information about particular conditions (including HPV, herpes, syphilis, trichomoniasis, HIV and AIDS, and others) or related patient issues (such as STD exposure evaluation and evaluation of sexual assault), Sexually Transmitted Diseases, second edition, contains the knowledge doctors need in a friendly, to-the-point format.